A detailed history of Richard P Slaughter Associates Inc transactions in Pfizer Inc stock. As of the latest transaction made, Richard P Slaughter Associates Inc holds 137,371 shares of PFE stock, worth $3.43 Million. This represents 1.16% of its overall portfolio holdings.

Number of Shares
137,371
Previous 156,932 12.46%
Holding current value
$3.43 Million
Previous $4.39 Million 9.45%
% of portfolio
1.16%
Previous 1.17%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$27.7 - $31.39 $541,839 - $614,019
-19,561 Reduced 12.46%
137,371 $3.98 Million
Q2 2024

Jul 10, 2024

BUY
$25.26 - $29.6 $273,010 - $319,916
10,808 Added 7.4%
156,932 $4.39 Million
Q1 2024

Apr 09, 2024

BUY
$25.89 - $29.73 $977,451 - $1.12 Million
37,754 Added 34.84%
146,124 $4.05 Million
Q4 2023

Jan 08, 2024

BUY
$26.13 - $33.94 $14,397 - $18,700
551 Added 0.51%
108,370 $3.12 Million
Q3 2023

Oct 10, 2023

BUY
$32.09 - $37.51 $1.92 Million - $2.24 Million
59,821 Added 124.63%
107,819 $3.58 Million
Q2 2023

Jul 06, 2023

BUY
$36.12 - $41.79 $113,525 - $131,345
3,143 Added 7.01%
47,998 $1.76 Million
Q1 2023

Apr 18, 2023

BUY
$39.39 - $51.28 $56,879 - $74,048
1,444 Added 3.33%
44,855 $1.83 Million
Q4 2022

Jan 09, 2023

BUY
$41.75 - $54.5 $64,921 - $84,747
1,555 Added 3.72%
43,411 $0
Q3 2022

Oct 11, 2022

BUY
$43.76 - $53.42 $1.83 Million - $2.24 Million
41,856 New
41,856 $1.83 Million
Q4 2021

Jan 13, 2022

SELL
$41.32 - $61.25 $197,881 - $293,326
-4,789 Closed
0 $0
Q3 2021

Oct 06, 2021

BUY
$39.25 - $50.42 $187,968 - $241,461
4,789 New
4,789 $205,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $140B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Richard P Slaughter Associates Inc Portfolio

Follow Richard P Slaughter Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Richard P Slaughter Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Richard P Slaughter Associates Inc with notifications on news.